“There is a real cost to moving fast”: Using AI to accelerate drug discovery
On this episode of Leaders of Code, Maureen Makes, VP of Engineering at Recursion, discusses AI's role in drug discovery, scaling and integration challenges, and the importance of innovation in achieving the high standards desired.
